BE856860A - Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation - Google Patents

Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation

Info

Publication number
BE856860A
BE856860A BE179384A BE179384A BE856860A BE 856860 A BE856860 A BE 856860A BE 179384 A BE179384 A BE 179384A BE 179384 A BE179384 A BE 179384A BE 856860 A BE856860 A BE 856860A
Authority
BE
Belgium
Prior art keywords
androstan
derivatives
preparing
products obtained
products
Prior art date
Application number
BE179384A
Other languages
English (en)
French (fr)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BE856860A publication Critical patent/BE856860A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE179384A 1976-07-16 1977-07-15 Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation BE856860A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
BE856860A true BE856860A (fr) 1978-01-16

Family

ID=5983514

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179384A BE856860A (fr) 1976-07-16 1977-07-15 Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation

Country Status (18)

Country Link
US (1) US4179336A (da)
JP (1) JPS5315493A (da)
AT (1) AT363196B (da)
BE (1) BE856860A (da)
CH (3) CH627190A5 (da)
CS (1) CS200517B2 (da)
DD (4) DD136141A5 (da)
DE (1) DE2632677A1 (da)
DK (1) DK142372C (da)
FR (4) FR2365588A1 (da)
GB (1) GB1585786A (da)
HU (4) HU182790B (da)
IE (1) IE45304B1 (da)
IT (1) IT1077339B (da)
NL (1) NL7706638A (da)
SE (1) SE440779B (da)
SU (1) SU980628A3 (da)
YU (1) YU164277A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
JPH0512528Y2 (da) * 1987-09-08 1993-03-31
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Shokubai Co., Ltd. Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
PT2644206T (pt) * 2003-05-23 2019-07-10 Nektar Therapeutics Derivados de peg contendo duas cadeias de peg
EP2495242B1 (en) * 2009-10-29 2016-05-04 Industry-Academic Cooperation Foundation Yonsei University Novel vascular leak inhibitor
US9388210B2 (en) 2011-02-25 2016-07-12 Washington University Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
CN108976272B (zh) 2011-10-14 2021-05-25 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
TR201808616T4 (tr) 2012-12-18 2018-07-23 Sage Therapeutics Inc Nöroaktif 19-alkoksi-17-ikameli steroidler, bunların ön ilaçları ve bunları kullanan tedavi yöntemleri.
US10202413B2 (en) 2013-02-15 2019-02-12 Washington University Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
HUE041369T2 (hu) 2013-04-17 2019-05-28 Sage Therapeutics Inc 19-nor C3,3-diszubsztituált C21-N-pirazolil-szteroidok és eljárás ezek alkalmazására
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
CA3199003A1 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CA3235088A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
MX2017005002A (es) 2014-10-16 2018-01-23 Sage Therapeutics Inc Composiciones y metodos para el tratamiento de trastornos del snc.
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
IL309259A (en) 2016-07-11 2024-02-01 Sage Therapeutics Inc C17, C20 and C21 converted neuroactive steroids and methods of using them
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス， インコーポレイテッド Ｃ７、ｃ１２、およびｃ１６置換神経刺激性ステロイドおよびそれらの使用方法
MA56046A (fr) 2019-05-31 2022-04-06 Sage Therapeutics Inc Stéroïdes neuroactifs et compositions associées

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (da) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Also Published As

Publication number Publication date
GB1585786A (en) 1981-03-11
HU179344B (en) 1982-10-28
SU980628A3 (ru) 1982-12-07
FR2365588A1 (fr) 1978-04-21
IT1077339B (it) 1985-05-04
FR2372176A1 (fr) 1978-06-23
IE45304B1 (en) 1982-07-28
FR2372175A1 (fr) 1978-06-23
CH627190A5 (da) 1981-12-31
HU182681B (en) 1984-02-28
JPS6117477B2 (da) 1986-05-07
ATA504677A (de) 1980-12-15
DK323677A (da) 1978-01-17
CH629503A5 (de) 1982-04-30
AT363196B (de) 1981-07-10
CS200517B2 (en) 1980-09-15
HU182789B (en) 1984-03-28
DD132439A5 (de) 1978-09-27
IE45304L (en) 1978-01-16
DK142372C (da) 1981-03-23
CH629222A5 (de) 1982-04-15
DK142372B (da) 1980-10-20
DD136142A5 (de) 1979-06-20
DD137235A5 (de) 1979-08-22
DE2632677A1 (de) 1978-01-26
DE2632677C2 (da) 1988-06-16
JPS5315493A (en) 1978-02-13
SE7708192L (sv) 1978-01-17
NL7706638A (nl) 1978-01-18
FR2372174A1 (fr) 1978-06-23
DD136141A5 (de) 1979-06-20
YU164277A (en) 1982-08-31
SE440779B (sv) 1985-08-19
US4179336A (en) 1979-12-18
FR2365588B1 (da) 1982-06-25
HU182790B (en) 1984-03-28

Similar Documents

Publication Publication Date Title
BE856860A (fr) Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation
BE860971A (fr) Procede de preparation de n,n'-methylenebis-(0,0-diaryl n-phosphonomethylglycinonitriles, nouveaux produits ainsi obtenus et leur utilisation
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
BE843248A (fr) Procede de preparation de phtalonitrile, et produit obtenu
FR2287435A1 (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4-pyranones-2
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
BE841285A (fr) Procede de preparation d'acetoacetyl-arylamides
BE855236A (fr) Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation
BE842940A (fr) Procede de preparation d'oxaphospholannes-1,2,
LU80346A1 (fr) Procede de preparation d'un produit alimentaire ameliore
IT1146228B (it) Procedimento per preparare 2,6-dialchil-n-alcossimetil-2-cloro-acetanilidi e prodotto ottenuto
BE855371A (fr) Procede de preparation de 1,1-difluorethylene
FR2333805A1 (fr) Procede de preparation de n,n'-bis-trimethylsilyluree
FR2299329A1 (fr) Procede de preparation de 1,2-benzisothiazoles
BE841471A (fr) Procede de preparation d'humulone et produit obtenu
BE866588A (fr) Derives de 2-benzyl-perhydroazepines, procede pour leur preparation et application comme medicaments
FR2310998A1 (fr) Procede de preparation de la 2,5-dimethoxy-4-chloraniline
FR2307781A1 (fr) Procede de preparation d'acenaphtenes
BE848627A (fr) Derives substitues d'aminobenzaldehydes et leur procede de preparation,
BE858387A (fr) Procede pour la preparation de 2,3-cycloalkenopyridines et produits obtenus
BE841577A (fr) Procede de preparation de derives de 21-hydroxy-16-pregnen-20-one, et produits obtenus
FR2334654A1 (fr) Procede de preparation d'halogeno-nitrobenzenes
BE848388A (fr) Procede de preparation de monohydrate d'ethercarboxylate et nouveau produit ainsi obtenu,
BE877695A (fr) Derives de 2,4,6-triiodo-benzene, leur procede de preparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCHERING A.G.

Effective date: 19920731